An oral cleaning and/or treatment device includes electrodes for emitting RF energy for providing an oral cleaning and/or treatment function. The device includes a cleaning unit for receipt in an oral cavity which includes at least a first and second protruding member, which protrude in a same general direction away from abase or support structure. Each member comprises one or more electrodes or conductive elements for emitting RF energy. The device generates an RF field in a space between and around the electrodes by driving the electrodes with an RF signal generator. The device includes means, either mechanical or electrical, for varying a generated RF field pattern (e.g. spatial intensity distribution) between different settings. The device is in particular configurable in at least two modes or settings, each associated with a different respective field pattern or spatial intensity distribution. This is valuable for adapting the cleaning functionality to different required purposes.

Mandibular repositioning devices have a mandibular piece having a first teeth covering and having a housing proximate each of a left molar portion and a right molar portion, a protrusive flange extending cranially from each housing, and a maxillary piece having a second teeth covering and having a housing proximate each of a left molar portion and a right molar portion. Each housing encloses a power source electrically connected an on-board circuit board and the housings of the maxillary piece further have the power source electrically connected to a motor operatively connected to a drive for anterior and posterior movements of the mandibular piece. The maxillary piece sits on the mandibular piece with the driver operatively engaged with the protrusive flange. The protrusive flange has a concavely-shaped anterior surface mated to a convexly-shaped head of the driver shaped to match the concavely-shaped anterior surface of the protrusive flange.

A method includes receiving respiration data associated with respiration of a user from a respiration monitoring device that is positioned inside the user adjacent to a thoracic cavity of the user. The method also includes determining, based at least in part on the respiration data associated with respiration of the user, a respiration signal for the user. The method also includes determining, based at least in part on the respiration signal, a predicted start time for a future inhalation of the user. The method also includes causing a stimulation device to provide electrical stimulation to one or more branches of a nerve of the user at the predicted start time, the stimulation device being positioned inside the user adjacent to a tongue of the user and being physically separated from the respiration monitoring device.

A method of treating obstructive sleep apnea according to this disclosure may include: providing an implant comprising a substantially planar central body portion having a top side and a bottom side; at least two adjustable wing portions; and at least two connecting members, each one of the at least two connecting members extending from opposite sides of the central body portion, the each one of the at least two connecting members being configured for flexibly connecting each one of the at least two wing portions at opposite sides to said central body portion; forming a surgical opening to expose a genioglossus muscle; exposing a branch of a hypoglossal nerve for stimulation by the implant at least on one side of the geniouglossus; forming at least one pocket on at least one side of the geniouglossus; such that the pocket dimensions are configured to fit the at least one of the at least two wing portions of the device; inserting an implant device through the surgical opening such that the central body extends over the genioglossus and each one of the wing portions is received in the respective at least one pocket; and securing the implant device to the muscle.

Bacteria, cancer cells, fungus and other harmful cells located beneath the surface of a mammal body can be effectively destroyed by passing an electrical current through the area to be treated. Electrodes are positioned on either side of the area to be treated, for example, gums, fingers, arms, legs, feet and torso, and an electric current is caused to flow between the electrodes and through the area to be treated. The electric current will destroy the bacteria, cancer cells, fungus or other harmful cells.

A micro, single piece, tubeless, cordless, directly inserted oral, nasal or hybrid sleep apnea treatment/anti-snoring device having controlled positive air-flow using a vibrationally isolated micro-blower to maintain an individual's upper airway unobstructed (pharynx area) with or without lower jaw, mandibular advancement is disclosed.

Apnea events may be detected based on a primary biomarker, e.g., respiration, in the one or more physiological signals. The apnea events may be characterized as one of an obstructive sleep apnea (OSA) event, a central sleep apnea (CSA) event, or a combination OSA/CSA event based on a secondary biomarker, e.g., a frequency spectrum or a morphology of the respirations in the one or more physiological signals. A first electrical stimulation may be provided to treat OSA in response to a first one or more of the apnea events being characterized as OSA events. A second electrical stimulation may be provided to treat CSA in response to a second one or more of apnea events being characterized as CSA events. A third electrical stimulation may be provided to treat combination OSA/CSA in response to a third one or more of the apnea events being characterized as combination OSA/CSA events.

Apnea events may be detected based on a primary biomarker, e.g., respiration, in the one or more physiological signals. The apnea events may be characterized as one of an obstructive sleep apnea (OSA) event, a central sleep apnea (CSA) event, or a combination OSA/CSA event based on a secondary biomarker, e.g., a frequency spectrum or a morphology of the respirations in the one or more physiological signals. A first electrical stimulation may be provided to treat OSA in response to a first one or more of the apnea events being characterized as OSA events. A second electrical stimulation may be provided to treat CSA in response to a second one or more of apnea events being characterized as CSA events. A third electrical stimulation may be provided to treat combination OSA/CSA in response to a third one or more of the apnea events being characterized as combination OSA/CSA events.

Provided is a monopolar skin treatment apparatus using electrical energy in a high frequency wavelength band in which a retaining ligament, a blood vessel, and a fibrous tissue of a deep part is utilized as an electricity passage to actively prevent the skin from sagging due to the aging. The mouthpiece for skin treatment includes a frame, and a ground electrode unit on the frame. The frame includes a first frame disposed in front, a second frame extending rearward from one end portion of the first frame, and a third frame extending rearward from an opposite end portion of the first frame. The ground electrode unit is integrally formed with the first frame, the second frame, and the third frame while continuously extending.

An intraoral stimulation device configured to be positioned in a mouth of a patient. The device includes a sensor and one or more electrodes. The sensor is configured to monitor a position of the tongue and/or force exerted by the tongue against the sensor and to transmit a signal encoding tongue information. The electrode(s) is/are configured to deliver electrical stimuli to the patient's hard palate when the tongue information indicates that the tongue has moved from a desired position to an undesired position in the mouth. The electrical stimuli causes the tongue to move from the undesired position to the desired position.